Susan

UCI and Syntropy Announce Five-Year Strategic Partnership to Improve Patient Care Through Unprecedented Data Integration

Retrieved on: 
Wednesday, October 6, 2021
Science, Other Science, Research, General Health, Health, Data Management, Technology, Other Technology, U.S. News & World Report, Partnership, Wellness, Education, Health Affairs, Susan, PLTR, Solution, Health, News, Student, Bouvé College of Health Sciences, Patient, Population, Physician, Association, Outline of health sciences, LinkedIn, Foundry, Twitter, Nobel, University, Merck, Life, Center, Merck Group, Medical diagnosis, Disease, Susan Henry, Information technology, Science, Research, University of California, Irvine Medical Center, Organization, Learning, EMD, Ecosystem, Association of American Universities, Foot, Chief digital officer, NYSE, College, DAX, College of Health Sciences, UCI, Medical device, Medicine, Pharmaceutical industry, the University of California, Irvine, Syntropy, THE UNIVERSITY OF CALIFORNIA, IRVINE, SYNTROPY

This strategic collaboration evolves from a natural synergy between both organizations in their mission to improve the delivery of patient care through better utilization of data.

Key Points: 
  • This strategic collaboration evolves from a natural synergy between both organizations in their mission to improve the delivery of patient care through better utilization of data.
  • The partnership brings to life the UCI Health Affairs vision of seamlessly connecting clinical-, research- and patient-reported data across the entire research enterprise.
  • Sharing data in this trusted and secure environment can lead to a network effect that creates augmented insights derived from real-world data.
  • UCI and Syntropy are creating an innovative model for how health organizations approach collecting and transforming insights from health data.

CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors

Retrieved on: 
Monday, October 4, 2021
UCSF, Therapy, Medicine, Â, Susan, BRCA2, Royal Society, University, Cancer Research UK, SAN, Safety, Tumor microenvironment, Breast cancer, PARP, Academy, Technology, Biotechnology, Research, Academy of Medical Sciences (United Kingdom), LinkedIn, CD166, Twitter, Bristol Myers Squibb, Royal, Imperial College London, FRS, European Molecular Biology Organization, United, Biochemistry, Clinical trial, Breast, Neoplasm, Oncology, Samuel, Cancer, Institute, The Genetics Society, Toxicity, Company, European Society for Medical Oncology, Risk, University College London, Drug discovery, GLOBE, University of California, ADP, CD71, Doctor of Philosophy, Patient, University of London, Chemistry, COVID-19, AbbVie, Nasdaq, Meyenburg, Pharmaceutical industry, Management

It is a privilege to welcome Alan to our board, commented Sean McCarthy, D.Phil., president, chief executive officer and chairman of CytomX Therapeutics.

Key Points: 
  • It is a privilege to welcome Alan to our board, commented Sean McCarthy, D.Phil., president, chief executive officer and chairman of CytomX Therapeutics.
  • It is my pleasure to join CytomXs board as the Company continues to innovate and advance its broad and diverse pipeline of potential first-in-class product candidates, said Dr. Ashworth.
  • I look forward to working with the entire board and the executive team to help advance CytomXs vision of bringing more effective therapies to cancer patients.
  • For additional information about CytomX Therapeutics, visit www.cytomx.com and follow us on LinkedIn and Twitter .

Avocados From Mexico Announces New Partnership with Susan G. Komen®

Retrieved on: 
Tuesday, September 28, 2021
Public relations, Green Bay Packers, Partnership, Man, Avocado, Susan, Breast cancer, Mineral, Health, Advertising, AFM, Patient, Association, CEO, Program, Life, Woman, Love, Awareness, Disease, Research, Vitamin, Cooking, Birth control, Drug

And, it's through our diverse staff including more than 60% women that unique partnerships like this one come to life," said Alvaro Luque, President and CEO of Avocados From Mexico.

Key Points: 
  • And, it's through our diverse staff including more than 60% women that unique partnerships like this one come to life," said Alvaro Luque, President and CEO of Avocados From Mexico.
  • The Susan G. Komen Avocado Bag will be highlighted on the Komen's Live Pink online catalog , as well as the Susan G. Komen partner page here .
  • Avocados From Mexico (AFM) is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico .
  • Susan G. Komen is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston

Retrieved on: 
Tuesday, September 28, 2021
Pharmaceutical, Other Consumer, Oncology, General Health, Women, Philanthropy, Sports, Men, Running, Foundation, Science, Other Philanthropy, Other Science, Consumer, Research, Health, HER2/neu, Cure, Cancer, Partnership, Friends, Susan, DTH, MD Anderson Cancer Center, Recurrence, Breast, Water, Map, Survivor, Patient, Population, Komen, Trastuzumab, Phase, Immunotherapy, Twitter, Company, Woman, Family, Disease, Greenwich, Research, Forward-looking statement, Prospectus, Doctor of Philosophy, Nasdaq, Breast cancer, SEC, Education, Dietary supplement, Birth control, Susan G. Komen, Breast Cancer and HER2/neu Positivity, Greenwich LifeSciences, Inc., GP2 Immunotherapy Immune Response, SUSAN G. KOMEN, BREAST CANCER AND HER2/NEU POSITIVITY, GREENWICH LIFESCIENCES, INC., GP2 IMMUNOTHERAPY IMMUNE RESPONSE

As a Bronze level sponsor and partner, the Company will be managing a water station, supporting the events race map, and participating in the race.

Key Points: 
  • As a Bronze level sponsor and partner, the Company will be managing a water station, supporting the events race map, and participating in the race.
  • Vice President Clinical and Regulatory Affairs Jaye Thompson, PhD commented, Greenwich is honored to be supporting the Race for the Cure.
  • Susan G. Komen, the worlds leading breast cancer organization, will hold the 3.1 mile race in downtown Houston.
  • Susan G. Komen is the worlds leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

BBX Capital, Inc. Appoints Marcia Barry-Smith to its Board of Directors

Retrieved on: 
Wednesday, September 22, 2021
Luxury, Other Retail, Family, Consumer, Building Systems, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Retail, Vacation, Lodging, Travel, Urban Planning, Finance, Landscape, Interior Design, Professional Services, Architecture, Home Goods, Humanity, Susan, Jamaican, Board of directors, Multimedia, OTCQX, CRA, BBX Capital Corporation, Board, Senior, CEO, Industry, PINK, University, Toronto, Leadership, Jewish Community Relations Council of Minnesota and the Dakotas, BankAtlantic, United Way, Renin, City, Trinity College, Habitat, Director, Holding company, Management

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (BBX Capital) announced today that its Board of Directors has appointed Ms. Marcia Barry-Smith to the Board of Directors.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (BBX Capital) announced today that its Board of Directors has appointed Ms. Marcia Barry-Smith to the Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20210922005847/en/
    BBX Capital, Inc. Appoints Marcia Barry-Smith to its Board of Directors (Photo: Business Wire)
    Marcia Barry-Smith is a renowned and highly respected professional within the South Florida community.
  • We are pleased to have Marcia join the BBX Capital Board of Directors.
  • We welcome Marcias leadership and experience, commented Jarett S. Levan, Chief Executive Officer and President of BBX Capital, Inc.
    About BBX Capital, Inc.: BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) is a Florida-based diversified holding company whose principal holdings include BBX Capital Real Estate, BBX Sweet Holdings, which includes ITSUGAR, and Renin.

Gallagher Joins Nashville Yards as Founding Partner, Expanding Company Presence in Downtown Nashville

Retrieved on: 
Tuesday, September 21, 2021
Entertainment, Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Destinations, Construction & Property, Travel, General Entertainment, Insurance, Urban Planning, REIT, Finance, Partnership, Yard, Instagram, Susan, Staples Center, Multimedia, Southwest Value Partners, Real estate, Heart, Coachella Valley Music and Arts Festival, Anschutz Entertainment Group, Twitter, Consultant, Pinnacle Financial Partners, Risk management, DCI Global Partnerships, STAPLES, Partner, Work, Special Olympics, Facility, LA Galaxy, Organization, AEG, Tennessee, NYSE, Nightclub, Tourism, Entertainment, Gallagher, Nashville Yards, AEG, GALLAGHER, NASHVILLE YARDS, AEG

Additionally, Gallagher will join Nashville Yards in organizing a series of philanthropic and service initiatives designed to support regional nonprofits and enhance the downtown community.

Key Points: 
  • Additionally, Gallagher will join Nashville Yards in organizing a series of philanthropic and service initiatives designed to support regional nonprofits and enhance the downtown community.
  • This partnership with Southwest Value Partners and AEG allows Gallagher to build a larger presence in Nashville while also reinforcing our longstanding commitment to community engagement and enrichment, said Jessica Govic, Gallagher Area President.
  • Gallagher and Nashville Yards have also agreed to jointly organize and participate in an annual city-wide cleanup event that will extend through downtown Nashville.
  • Nashville Yards is an 18-acre project located in the heart of downtown Nashville.

Columbus Capital Launches New Community Impact Campaign and Retains PR Firm

Retrieved on: 
Friday, September 17, 2021
CCL, Movement, Quality of life, Technology, Facebook, Marketing, Columbus Capitals, COVID-19, Public relations, View, Safety, COO, Multimedia, Susan, COVID, Organization, Social media, Awareness, Cryptocurrency

The senior management department of Columbus Capital Lending felt that as a company, a specific focus needed to be implemented to aid those affected by the COVID pandemic in the South Florida community.

Key Points: 
  • The senior management department of Columbus Capital Lending felt that as a company, a specific focus needed to be implemented to aid those affected by the COVID pandemic in the South Florida community.
  • With both pride and humility, Columbus Capital will launch the "CCL Gives Back" campaign.
  • Collaborating with Columbus Capital Lending's in-house team, the firm will aid in casting a wider net as it relates to educating, supporting, and strengthening our social fabric on sustainable homeownership.
  • Columbus Capital lending has aggressively sought to become a national force for sustainable homeownership, reaching out to underserved communities and expanding to other markets.

Trellus Health: First Demonstration Contract with Mount Sinai Employee Health Plan for Resilience-Based Digital Chronic Condition Management

Retrieved on: 
Friday, September 17, 2021
IBD, Crohn's disease, Mount Sinai Health System, U.S. News & World Report, Icahn School of Medicine at Mount Sinai, Honors student, Education, Achievement, Disease, NEW, Mount Sinai Hospital (Manhattan), Hospital, Mental health, LSE, Technology, Inflammatory bowel disease, Health, Adoption, Diabetes, Doctor of Philosophy, Patient, Kidney disease, RN, Company, View, Agreement, Ulcerative colitis, Physician, News, Solution, MD, Irritable bowel syndrome, Mount Sinai Hospital, Multimedia, Susan, Cancer, AIM, MPA, Health insurance, Medical device, Medicine

This initial Agreement will assess feasibility, engagement and satisfaction of the Company's digital chronic condition management solution for Mount Sinai's non-union employees, eligible dependents and their treating physicians.

Key Points: 
  • This initial Agreement will assess feasibility, engagement and satisfaction of the Company's digital chronic condition management solution for Mount Sinai's non-union employees, eligible dependents and their treating physicians.
  • The GRITTTMresilience assessment and personalized treatment methodologydescribed is based on technology developed by Mount Sinai faculty and licensed to Trellus Health.
  • Mount Sinai and Mount Sinai faculty, including Marla Dubinsky, MD, and Laurie Keefer, PhD, have a financial interest in Trellus Health.
  • Trellus Health (LSE: TRLS) is a leading pioneer in resilience-driven care and the first digital health company focused on the intersection of chronic physical conditions and mental health.

Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path

Retrieved on: 
Tuesday, August 24, 2021
Harvard School of Dental Medicine, Massachusetts Institute of Technology, Prognosis, Diagnosis, GLOBE, Oncology, Master of Science, Harvard Medical School, Massachusetts, Doctor of Philosophy, Swiss Precision Diagnostics, Merck & Co., MPH, MIT Sloan School of Management, MBA, Internal medicine, Public health, H&E, Hospital, Hematology, Harvard T.H. Chan School of Public Health, FDA, Breast cancer, Histology, Susan, Dana–Farber Cancer Institute, Medical imaging, Management

NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path , creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A. Bunnell, MD, MPH, MBA, has joined the companys distinguished advisory board.

Key Points: 
  • NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path , creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A. Bunnell, MD, MPH, MBA, has joined the companys distinguished advisory board.
  • Dr. Bunnell serves as Dana-Farber Cancer Institutes chief medical officer and as a member of Dana-Farbers Breast Oncology Center in the Susan F. Smith Center for Womens Cancers.
  • 4D Paths Q-Plasia OncoReader is a U.S. patented, novel pan-cancer precision diagnostic and oncology platform, unveiling previously hidden data in H&E-stained tissue images.
  • The companys cloud-based 4D Q-Plasia OncoReader (QPOR) is a U.S. patented, novel, pan-cancer precision diagnostic and oncology platform, which extracts diagnostic data from routine cytology and histology images.